During the past decade, Mount Sinai Medical Center conducted 259 clinical trials. In the 10-year time frame, 259 clinical trials started and 190 clinical trials were completed, i.e. on average, 73.4% percent of trials that started reached the finish line to date. In the past 5 years, 124 clinical trials started and 92 clinical trials were completed. i.e. 74.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Mount Sinai Medical Center" #1 sponsor was "Alliance for Clinical Trials in Oncology" with 76 trials, followed by "National Institute of Allergy and Infectious Diseases (NIAID)" with 70 trials sponsored, "Boston Scientific Corporation" with 19 trials sponsored, "Children's Oncology Group" with 19 trials sponsored and "National Cancer Institute (NCI)" with 19 trials sponsored. Other sponsors include 569 different institutions and companies that sponsored additional 304 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Mount Sinai Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 149 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 19 trials as a collaborator, "Cancer and Leukemia Group B" with 18 trials as a collaborator, "National Institute of Mental Health (NIMH)" with 17 trials as a collaborator and "National Institute on Drug Abuse (NIDA)" with 15 trials as a collaborator. Other collaborators include 399 different institutions and companies that were collaborators in the rest 253 trials.

According to Clinical.Site data, the most researched conditions in "Mount Sinai Medical Center" are "HIV Infections" (106 trials), "Multiple Myeloma" (38 trials), "Leukemia" (27 trials), "Lymphoma" (19 trials) and "Breast Cancer" (18 trials). Many other conditions were trialed in "Mount Sinai Medical Center" in a lesser frequency.

Most popular intervention types in "Mount Sinai Medical Center" are "Drug" (513 trials), "Device" (111 trials), "Biological" (100 trials), "Other" (69 trials) and "Procedure" (58 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (71 trials), "Zidovudine" (25 trials), "cyclophosphamide" (25 trials), "doxorubicin hydrochloride" (17 trials) and "paclitaxel" (17 trials). Other intervention names were less common.

The vast majority of trials in "Mount Sinai Medical Center" are 719 trials for "All" genders, 33 trials for "Female" genders and 25 trials for "Male" genders.

Currently, there are 157 active trials in "Mount Sinai Medical Center". 1 are not yet recruiting, 79 are recruiting, 74 are Active, not recruiting, and 3 are Enrolling by invitation. In total, there were 504 completed trials in Mount Sinai Medical Center, 3 suspended trials, and 88 terminated clinical trials to date.

Out of the total trials that were conducted in Mount Sinai Medical Center, 96 "Phase 1" clinical trials were conducted, 257 "Phase 2" clinical trials and 202 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 24 trials, and there were also 131 trials that are defined as “Not Applicable".

Mount Sinai Medical Center has several departments that took part in Clinical trials: "Mount Sinai Med Ctr / Pediatrics" - 16 trials, "Beth Israel Med Ctr / Pediatrics" - 9 trials, "Mount Sinai Faculty Practice Associates" - 9 trials, "Mount Sinai School of Medicine Dermatology Clinical Trials" - 7 trials, "Mount Sinai School of Medicine - Medicine - Infectious Diseases" - 6 trials, "Department of Ophthalmology, Mount Sinai School of Medicine" - 5 trials, "Mt. Sinai Medical Center Division of Hematology/Oncology" - 4 trials, "Mount Sinai School of Medicine Department of Urology" - 4 trials, "Mount Sinai Kravis Children's Hospital" - 4 trials, "Beth Israel Medical Center - Singer Division" - 4 trials, "Mount Sinai Doctors Dermatology" - 3 trials, "Department of Psychiatry, Eating and Weight Disorders Program" - 3 trials, "St. Luke's Roosevelt Hospital Echocardiography Lab" - 3 trials, "The Fragile X Spectrum Disorder Clinic at Icahn School of Medicine at Mount Sinai, Division of Medical Genetics" - 3 trials, "Icahn School of Medicine at Mount Sinai: Department of Pediatrics Allergy & Immunology" - 2 trials, "Mt. Sinai School of Medicine, Div. of Ped. Infectious Diseases" - 2 trials, "Mount Sinai Movement Disorders Center" - 2 trials, "Mood Disorders Research Program, St. Luke's-Roosevelt Hospital Center" - 2 trials, "Mount Sinai Tisch Cancer Institute" - 2 trials, "Cross County Cardiology" - 2 trials